1. Home
  2. IMNN vs BTBD Comparison

IMNN vs BTBD Comparison

Compare IMNN & BTBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

HOLD

Current Price

$2.00

Market Cap

8.4M

Sector

Health Care

ML Signal

HOLD

Logo BT Brands Inc.

BTBD

BT Brands Inc.

HOLD

Current Price

$1.15

Market Cap

7.2M

ML Signal

HOLD

Company Overview

Basic Information
Metric
IMNN
BTBD
Founded
1982
1987
Country
United States
United States
Employees
N/A
188
Industry
Biotechnology: Pharmaceutical Preparations
Restaurants
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
8.4M
7.2M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
IMNN
BTBD
Price
$2.00
$1.15
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
48.2K
64.8K
Earning Date
05-14-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$1.03
52 Week High
$9.32
$5.59

Technical Indicators

Market Signals
Indicator
IMNN
BTBD
Relative Strength Index (RSI) 28.22 42.58
Support Level N/A $1.15
Resistance Level $2.50 $1.22
Average True Range (ATR) 0.15 0.06
MACD 0.00 0.03
Stochastic Oscillator 14.55 53.33

Price Performance

Historical Comparison
IMNN
BTBD

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About BTBD BT Brands Inc.

BT Brands Inc operates and owns a fast-food restaurant called Burger Time. Its offerings include a variety of burgers and other affordable items, including sides and soft drinks. The company owns and operates Keegan's Seafood Grille (Keegan's), a dine-in restaurant located in Florida; Pie In The Sky Coffee and Bakery (PIE), located in Massachusetts; and Schnitzel Haus, a German-themed restaurant located in Florida. The company's revenues are derived from the sale of food and beverages at its restaurants.

Share on Social Networks: